E-ISSN 2218-6050 | ISSN 2226-4485
 

Research Article


Characterization of the camel pox virus strain used in producing camel pox virus vaccine

Kydyrbay Maikhin, Maxat Berdikulov, Abdikalyk Abishov, Yerlan Pazylov, Gulzhan Mussayeva, Slukyz Zhussambayeva, Gulmira Janabekova, Ainash Shaimbetova, Yessengali Ussenbekov, Nazym Syrym.


Abstract
Background:
The camel pox virus is a widespread infectious viral disease of camels. It is necessary to conduct research on new strains for the development of vaccines.
Aim:
The research aims to characterize a novel strain isolated from the camel pox virus used to produce a camel pox virus vaccine.
Methods:
The objects of the study were the “M-0001” strain isolated from a sample of animals infected with the camel pox virus during the epidemic. The cultural and reproductive properties of the virus isolate were studied using primary cell lines from primary trypsinized lamb kidney and testicular cell cultures (LK and LT). Other samples included kidney cell lines from transplanted sheep) as well as a kidney cell line from transplanted cattle, Vero (transplanted green monkey kidney cell line), and calf trachea. The strain was PCR-tested and sequenced for characterization purposes.
Results:
The PCR results show that the study sample is species specific and corresponds to the camel pox virus by the size of the cumulative amplifications, which is 241 bp. Given the maximum percentage of a sequence match analyzed by the BLAST algorithm based on the international database and the results of phylogenetic analysis, the M0001 sample was determined to belong to the Camel pox virus (gene bank inventory number KP768318.1).
Conclusion:
The sample “M0001” is located on the same branch with a representative from CMLV (Camel pox virus). Among the cell cultures tested, the LK and LT cell lines were the most sensitive to the isolated CMLV isolate. Reproducing the virus in these cell cultures remains stable even after 15 consecutive passes. The cytopathic effect of the virus was less pronounced and low in transplanted cell lines, and the cytopathic effect was no longer apparent in the third passage. A genome alignment of the virus has identified potentially conserved sites, and analysis of loci in different virus types revealed one maximally conserved locus. An epizootic strain of the camelina virus “M-0001” candidate to produce vaccines for the camels was obtained. An experimental vaccine sample based on an isolated and charred camellia virus will be created in the future.

Key words: Camel, Camel pox virus, Isolate, Primary and transplanted cell culture lines, Virus titer


 
ARTICLE TOOLS
Abstract
PDF Fulltext
HTML Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Kydyrbay Maikhin
Articles by Maxat Berdikulov
Articles by Abdikalyk Abishov
Articles by Yerlan Pazylov
Articles by Gulzhan Mussayeva
Articles by Slukyz Zhussambayeva
Articles by Gulmira Janabekova
Articles by Ainash Shaimbetova
Articles by Yessengali Ussenbekov
Articles by Nazym Syrym
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Maikhin K, Berdikulov M, Abishov A, Pazylov Y, Mussayeva G, Zhussambayeva S, Janabekova G, Shaimbetova A, Ussenbekov Y, Syrym N. Characterization of the camel pox virus strain used in producing camel pox virus vaccine. Open Vet J. 2023; 13(5): 558-568. doi:10.5455/OVJ.2023.v13.i5.8


Web Style

Maikhin K, Berdikulov M, Abishov A, Pazylov Y, Mussayeva G, Zhussambayeva S, Janabekova G, Shaimbetova A, Ussenbekov Y, Syrym N. Characterization of the camel pox virus strain used in producing camel pox virus vaccine. https://www.openveterinaryjournal.com/?mno=93653 [Access: March 13, 2024]. doi:10.5455/OVJ.2023.v13.i5.8


AMA (American Medical Association) Style

Maikhin K, Berdikulov M, Abishov A, Pazylov Y, Mussayeva G, Zhussambayeva S, Janabekova G, Shaimbetova A, Ussenbekov Y, Syrym N. Characterization of the camel pox virus strain used in producing camel pox virus vaccine. Open Vet J. 2023; 13(5): 558-568. doi:10.5455/OVJ.2023.v13.i5.8



Vancouver/ICMJE Style

Maikhin K, Berdikulov M, Abishov A, Pazylov Y, Mussayeva G, Zhussambayeva S, Janabekova G, Shaimbetova A, Ussenbekov Y, Syrym N. Characterization of the camel pox virus strain used in producing camel pox virus vaccine. Open Vet J. (2023), [cited March 13, 2024]; 13(5): 558-568. doi:10.5455/OVJ.2023.v13.i5.8



Harvard Style

Maikhin, K., Berdikulov, . M., Abishov, . A., Pazylov, . Y., Mussayeva, . G., Zhussambayeva, . S., Janabekova, . G., Shaimbetova, . A., Ussenbekov, . Y. & Syrym, . N. (2023) Characterization of the camel pox virus strain used in producing camel pox virus vaccine. Open Vet J, 13 (5), 558-568. doi:10.5455/OVJ.2023.v13.i5.8



Turabian Style

Maikhin, Kydyrbay, Maxat Berdikulov, Abdikalyk Abishov, Yerlan Pazylov, Gulzhan Mussayeva, Slukyz Zhussambayeva, Gulmira Janabekova, Ainash Shaimbetova, Yessengali Ussenbekov, and Nazym Syrym. 2023. Characterization of the camel pox virus strain used in producing camel pox virus vaccine. Open Veterinary Journal, 13 (5), 558-568. doi:10.5455/OVJ.2023.v13.i5.8



Chicago Style

Maikhin, Kydyrbay, Maxat Berdikulov, Abdikalyk Abishov, Yerlan Pazylov, Gulzhan Mussayeva, Slukyz Zhussambayeva, Gulmira Janabekova, Ainash Shaimbetova, Yessengali Ussenbekov, and Nazym Syrym. "Characterization of the camel pox virus strain used in producing camel pox virus vaccine." Open Veterinary Journal 13 (2023), 558-568. doi:10.5455/OVJ.2023.v13.i5.8



MLA (The Modern Language Association) Style

Maikhin, Kydyrbay, Maxat Berdikulov, Abdikalyk Abishov, Yerlan Pazylov, Gulzhan Mussayeva, Slukyz Zhussambayeva, Gulmira Janabekova, Ainash Shaimbetova, Yessengali Ussenbekov, and Nazym Syrym. "Characterization of the camel pox virus strain used in producing camel pox virus vaccine." Open Veterinary Journal 13.5 (2023), 558-568. Print. doi:10.5455/OVJ.2023.v13.i5.8



APA (American Psychological Association) Style

Maikhin, K., Berdikulov, . M., Abishov, . A., Pazylov, . Y., Mussayeva, . G., Zhussambayeva, . S., Janabekova, . G., Shaimbetova, . A., Ussenbekov, . Y. & Syrym, . N. (2023) Characterization of the camel pox virus strain used in producing camel pox virus vaccine. Open Veterinary Journal, 13 (5), 558-568. doi:10.5455/OVJ.2023.v13.i5.8